3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells

Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular medicine (Berlin, Germany) Germany), 2021-03, Vol.99 (3), p.425-438
Hauptverfasser: Dubich, Tatyana, Dittrich, Anne, Bousset, Kristine, Geffers, Robert, Büsche, Guntram, Köster, Mario, Hauser, Hansjörg, Schulz, Thomas F., Wirth, Dagmar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 438
container_issue 3
container_start_page 425
container_title Journal of molecular medicine (Berlin, Germany)
container_volume 99
creator Dubich, Tatyana
Dittrich, Anne
Bousset, Kristine
Geffers, Robert
Büsche, Guntram
Köster, Mario
Hauser, Hansjörg
Schulz, Thomas F.
Wirth, Dagmar
description Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions. Key messages In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures 3D maintenance of KSHV is associated with an increased de novo infection frequency PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance
doi_str_mv 10.1007/s00109-020-02020-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7900040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480493154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</originalsourceid><addsrcrecordid>eNp9kUtuFDEQhi0EIkPgAiyQJTZh0VB-9HR7g4QSICiRWPDYWh67OuOo227sdiR2uQbX4yR4mBAeCxa2paqvflfVT8hjBs8ZQPciAzBQDXDYnXr3d8iKScEbJiXcJStQct3wjq0PyIOcLyvetUreJwdCyF7ynq1IESfUlnEpCamNwfnFx5BpLvMc00LPzByz_379rYZMsnEydItpxnzlU8n06OzD6edndDI-LBhMsEhNcLQmzUjznNA46gPF4OKyxdHXqMVxzA_JvcGMGR_dvIfk05vXH49Pm_P3b98dvzpvrOzk0vTSdbJTwnCLVqm1GVgnoQXetwPienBuI53DjWA12Q69bRmg3TjmnMAWnDgkL_e6c9lM6CyGpXam5-Qnk77qaLz-OxP8Vl_EK90pAJBQBY5uBFL8UjAvevJ5N4IJGEvWXPYglWCtrOjTf9DLWFKo41VKccZ53X6l-J6yKeaccLhthoHeuar3rurqp_7pqu5r0ZM_x7gt-WVjBcQeqDv34QLT77__I_sDw_Kwfw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2492122175</pqid></control><display><type>article</type><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><source>SpringerLink Journals</source><creator>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</creator><creatorcontrib>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</creatorcontrib><description>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions. Key messages In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures 3D maintenance of KSHV is associated with an increased de novo infection frequency PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-020-02020-8</identifier><identifier>PMID: 33484281</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; Biomedical and Life Sciences ; Biomedicine ; Cell culture ; Effusion ; Endothelial cells ; Genomes ; Human Genetics ; Internal Medicine ; Kaposi's sarcoma ; Kaposis sarcoma ; Molecular Medicine ; Original ; Original Article ; Primary effusion lymphoma ; Sarcoma ; Therapeutic applications ; TOR protein ; Tumors ; Xenografts</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2021-03, Vol.99 (3), p.425-438</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</citedby><cites>FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</cites><orcidid>0000-0002-2541-6251</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-020-02020-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-020-02020-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33484281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubich, Tatyana</creatorcontrib><creatorcontrib>Dittrich, Anne</creatorcontrib><creatorcontrib>Bousset, Kristine</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Büsche, Guntram</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Schulz, Thomas F.</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions. Key messages In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures 3D maintenance of KSHV is associated with an increased de novo infection frequency PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell culture</subject><subject>Effusion</subject><subject>Endothelial cells</subject><subject>Genomes</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Kaposi's sarcoma</subject><subject>Kaposis sarcoma</subject><subject>Molecular Medicine</subject><subject>Original</subject><subject>Original Article</subject><subject>Primary effusion lymphoma</subject><subject>Sarcoma</subject><subject>Therapeutic applications</subject><subject>TOR protein</subject><subject>Tumors</subject><subject>Xenografts</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtuFDEQhi0EIkPgAiyQJTZh0VB-9HR7g4QSICiRWPDYWh67OuOo227sdiR2uQbX4yR4mBAeCxa2paqvflfVT8hjBs8ZQPciAzBQDXDYnXr3d8iKScEbJiXcJStQct3wjq0PyIOcLyvetUreJwdCyF7ynq1IESfUlnEpCamNwfnFx5BpLvMc00LPzByz_379rYZMsnEydItpxnzlU8n06OzD6edndDI-LBhMsEhNcLQmzUjznNA46gPF4OKyxdHXqMVxzA_JvcGMGR_dvIfk05vXH49Pm_P3b98dvzpvrOzk0vTSdbJTwnCLVqm1GVgnoQXetwPienBuI53DjWA12Q69bRmg3TjmnMAWnDgkL_e6c9lM6CyGpXam5-Qnk77qaLz-OxP8Vl_EK90pAJBQBY5uBFL8UjAvevJ5N4IJGEvWXPYglWCtrOjTf9DLWFKo41VKccZ53X6l-J6yKeaccLhthoHeuar3rurqp_7pqu5r0ZM_x7gt-WVjBcQeqDv34QLT77__I_sDw_Kwfw</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Dubich, Tatyana</creator><creator>Dittrich, Anne</creator><creator>Bousset, Kristine</creator><creator>Geffers, Robert</creator><creator>Büsche, Guntram</creator><creator>Köster, Mario</creator><creator>Hauser, Hansjörg</creator><creator>Schulz, Thomas F.</creator><creator>Wirth, Dagmar</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2541-6251</orcidid></search><sort><creationdate>20210301</creationdate><title>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</title><author>Dubich, Tatyana ; Dittrich, Anne ; Bousset, Kristine ; Geffers, Robert ; Büsche, Guntram ; Köster, Mario ; Hauser, Hansjörg ; Schulz, Thomas F. ; Wirth, Dagmar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-84d74793a2cec996af174050285fee6fddb4ddeb319965f8c510ecbd1dd3e50d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell culture</topic><topic>Effusion</topic><topic>Endothelial cells</topic><topic>Genomes</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Kaposi's sarcoma</topic><topic>Kaposis sarcoma</topic><topic>Molecular Medicine</topic><topic>Original</topic><topic>Original Article</topic><topic>Primary effusion lymphoma</topic><topic>Sarcoma</topic><topic>Therapeutic applications</topic><topic>TOR protein</topic><topic>Tumors</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubich, Tatyana</creatorcontrib><creatorcontrib>Dittrich, Anne</creatorcontrib><creatorcontrib>Bousset, Kristine</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Büsche, Guntram</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Schulz, Thomas F.</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubich, Tatyana</au><au>Dittrich, Anne</au><au>Bousset, Kristine</au><au>Geffers, Robert</au><au>Büsche, Guntram</au><au>Köster, Mario</au><au>Hauser, Hansjörg</au><au>Schulz, Thomas F.</au><au>Wirth, Dagmar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>99</volume><issue>3</issue><spage>425</spage><epage>438</epage><pages>425-438</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>Kaposi’s sarcoma–associated herpesvirus (KSHV) is a human tumorigenic virus and the etiological agent of an endothelial tumor (Kaposi’s sarcoma) and two B cell proliferative diseases (primary effusion lymphoma and multicentric Castleman’s disease). While in patients with late stage of Kaposi’s sarcoma the majority of spindle cells are KSHV-infected, viral copies are rapidly lost in vitro, both upon culture of tumor-derived cells or from newly infected endothelial cells. We addressed this discrepancy by investigating a KSHV-infected endothelial cell line in various culture conditions and in tumors of xenografted mice. We show that, in contrast to two-dimensional endothelial cell cultures, KSHV genomes are maintained under 3D cell culture conditions and in vivo. Additionally, an increased rate of newly infected cells was detected in 3D cell culture. Furthermore, we show that the PI3K/Akt/mTOR and ATM/γH2AX pathways are modulated and support an improved KSHV persistence in 3D cell culture. These mechanisms may contribute to the persistence of KSHV in tumor tissue in vivo and provide a novel target for KS specific therapeutic interventions. Key messages In vivo maintenance of episomal KSHV can be mimicked in 3D spheroid cultures 3D maintenance of KSHV is associated with an increased de novo infection frequency PI3K/Akt/mTOR and ATM/ γH2AX pathways contribute to viral maintenance</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33484281</pmid><doi>10.1007/s00109-020-02020-8</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-2541-6251</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0946-2716
ispartof Journal of molecular medicine (Berlin, Germany), 2021-03, Vol.99 (3), p.425-438
issn 0946-2716
1432-1440
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7900040
source SpringerLink Journals
subjects 1-Phosphatidylinositol 3-kinase
AKT protein
Biomedical and Life Sciences
Biomedicine
Cell culture
Effusion
Endothelial cells
Genomes
Human Genetics
Internal Medicine
Kaposi's sarcoma
Kaposis sarcoma
Molecular Medicine
Original
Original Article
Primary effusion lymphoma
Sarcoma
Therapeutic applications
TOR protein
Tumors
Xenografts
title 3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T10%3A02%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=3D%20culture%20conditions%20support%20Kaposi%E2%80%99s%20sarcoma%20herpesvirus%20(KSHV)%20maintenance%20and%20viral%20spread%20in%20endothelial%20cells&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Dubich,%20Tatyana&rft.date=2021-03-01&rft.volume=99&rft.issue=3&rft.spage=425&rft.epage=438&rft.pages=425-438&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-020-02020-8&rft_dat=%3Cproquest_pubme%3E2480493154%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2492122175&rft_id=info:pmid/33484281&rfr_iscdi=true